ArticleData in brief2017
A reconstructed melanoma data set for evaluating differential treatment benefit according to biomarker subgroups.
Article in Data in brief, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Assessment of Treatment Effects and Long-term Benefits in Immune Checkpoint Inhibitor Trials Using the Flexible Parametric Cure Model: A Systematic Review.JAMA network open · 2021Pooled it
- Conditional disease-free survival in high-risk renal cell carcinoma treated with sunitinib.Aging · 2019Trial
- Review
- Deconstructing the Kaplan-Meier curve: Quantification of treatment effect using the treatment effect process.Contemporary clinical trials · 2023Article
- Modeling the Cost-Effectiveness of Adjuvant Osimertinib for Patients with Resected EGFR-mutant Non-Small Cell Lung Cancer.The oncologist · 2022Article
- IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves.BMC medical research methodology · 2021Article
- Comparison of Local Recurrence Risk Estimates After Breast-Conserving Surgery for DCIS: DCIS Nomogram Versus Refined Oncotype DX Breast DCIS Score.Annals of surgical oncology · 2019Article
- Conditional Survival in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab.Medical science monitor : international medical journal of experimental and clinical research · 2019Article
- Data in support of high rate of pregnancy related deaths in Maiduguri, Borno State, Northeast Nigeria.Data in brief · 2018Article
- Quantitative evaluation of pregnant women delivery status' records in Akure, Nigeria.Data in brief · 2018Article
- Measuring differential treatment benefit across marker specific subgroups: The choice of outcome scale.Contemporary clinical trials · 2017Article
- Quantitative exploration of factors influencing psychotic disorder ailments in Nigeria.Data in brief · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The data presented in this article are related to the research article entitled "Measuring differential treatment benefit across marker specific subgroups: the choice of outcome scale" (Satagopan and Iasonos, 2015) [1]. These data were digitally reconstructed from figures published in Larkin et al. (2015) [2]. This article describes the steps to digitally reconstruct patient-level data on time-to-event outcome and treatment and biomarker groups using published Kaplan-Meier survival curves. The reconstructed data set and the corresponding computer programs are made publicly available to enable further statistical methodology research.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.